Tourette Syndrome Therapeutics - Pipeline Assessment

and Market Forecasts to 2019

On 1stDecember 2014

Summary
The industry analysis specialist, has released its new report, Tourette Syndrome Therapeutics
- Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Tourette Syndrome Therapeutics market. The report
identifies the key trends shaping and driving the global Tourette Syndrome Therapeutics
market. The report also provides insights on the prevalent competitive landscape and the
emerging players expected to significantly alter the market positioning of the current market
leaders. Most importantly, the report provides valuable insights on the pipeline products within
the global Tourette Syndrome Therapeutics sector. This report is built using data and
information sourced from proprietary databases, primary and secondary research and in-house
analysis by GlobalDatas team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-tourette-syndrome-therapeutics-pipeline-assessment-and-marketforecasts-135218

Scope
The report provides information on the key drivers and challenges of the Tourette Syndrome
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Tourette
Syndrome Therapeutics market revenues data from 2006 to 2011, forecast for eight years to
2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Tourette Syndrome
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Tourette Syndrome Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Tourette Syndrome
Therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Tourette Syndrome Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Tourette Syndrome Therapeutics
market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

partnerships.
- Whats the next big thing in the global Tourette Syndrome Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Tourette Syndrome Therapeutics - Introduction
2.1 Overview
2.1.1 Tourette Syndrome Classification Study Group
2.1.2 Classification of Tourette Syndrome
2.2 Etiology and Pathophysiology
2.2.1 Genetic Factors
2.2.2 Autoimmune Factors
2.2.3 Prenatal Difficulties
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.3 Epidemiology
2.3.1 The US
2.3.2 The UK
2.3.3 Italy
2.3.4 France
2.3.5 Germany
2.3.6 Spain
2.3.7 Quality of Life
2.3.8 Prognosis
2.3.9 Mortality
2.4 Symptoms
2.4.1 Motor Tics
2.4.2 Phonic Tics
2.4.3 Behavioral Symptoms
2.5 Diagnosis
2.5.1 Diagnostic and Statistical Manual of Mental Disorders - 4th Edition
2.5.2 Differential Diagnosis
2.6 Treatment and Management Pattern
2.6.1 Behavioral Therapy
2.6.2 Pharmacotherapy
2.6.3 Surgical Intervention
2.7 Referral Pathway
2.8 GlobalData Pipeline Report Guidance
3 Tourette Syndrome Therapeutics - Market Characterization
3.1 Tourette Syndrome Therapeutics Market Size
3.2 Tourette Syndrome Therapeutics Market Size (2006-2011) - Global
3.3 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Global
3.4 Tourette Syndrome Therapeutics Market Size (2006-2011) - The US
3.5 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - The US
3.6 Tourette Syndrome Therapeutics Market Size (2006-2011) - France
3.7 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - France
3.8 Tourette Syndrome Therapeutics Market Size (2006-2011) - Germany
3.9 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Germany
3.10 Tourette Syndrome Therapeutics Market Size (2006-2011) - Italy
3.11 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Italy
3.12 Tourette Syndrome Therapeutics Market Size (2006-2011) - Spain
3.13 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Spain
3.14 Tourette Syndrome Therapeutics Market Size (2006-2011) - The UK
3.15 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - The UK
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

3.16 Tourette Syndrome Therapeutics Market Size (2006-2011) - Japan

3.17 Tourette Syndrome Therapeutics Market Forecast (2011-2019) - Japan
3.18 Drivers and Barriers
3.18.1 Drivers for the Tourette Syndrome Therapeutics Market
3.18.2 Barriers to the Tourette Syndrome Therapeutics Market
3.19 Opportunity and Unmet Needs
3.20 Key Takeaway
4 Tourette Syndrome Therapeutics Market - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for the Major Marketed Products in the Tourette Syndrome Therapeutics
Market
4.3.1 Haloperidol
4.3.2 Pimozide
4.4 Key Takeaway
5 Tourette Syndrome Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Pipeline by Phase of Development
5.3.1 Phase III Pipeline
5.3.2 Phase II Pipeline
5.3.3 Phase I Pipeline
5.4 Tourette Syndrome Therapeutics Market - Pipeline by Mechanism of Action
5.5 Technology Trends Analytic Framework
5.6 Promising Drugs Under Development
5.7 Profile of Promising Drug
5.7.1 OPC-14597 (aripiprazole)
5.8 Key Takeaway
6 Tourette Syndrome Therapeutics - Clinical Trials Mapping
6.1 Overview
6.2 Clinical Trials by Region/Country
6.3 Clinical Trials by Phase
6.4 Clinical Trials by Trial Status
6.5 Prominent Sponsors
6.6 Key Companies Participating in Therapeutics Clinical Trials
7 Tourette Syndrome Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Future Market Competition
8 Tourette Syndrome - Future Players
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

8.1 Introduction
8.2 Company Profiles
8.2.1 Otsuka Holdings Co., Ltd
9 Appendix
9.1 Market Definitions
9.2 Abbreviations
9.3 Methodology
9.3.1 Coverage
9.3.2 Secondary Research
9.3.3 Forecasting
9.3.4 Primary Research
9.3.5 Expert Panel Validation
9.4 Contact Us
9.5 Disclaimer
9.6 Bibliography

List Of Tables
Table 1: Classification of Tourette Syndrome Based on Clinical Features
Table 2: Various Types of Tics Associated with Tourette Syndrome
Table 3: Pharmacotherapy Used for Treatment of Tourette Syndrome
Table 4: Tourette Syndrome Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 5: Tourette Syndrome Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 6: Tourette Syndrome Therapeutics Market, The US, Revenue ($m), 2006-2011
Table 7: Tourette Syndrome Therapeutics Market, The US, Forecast ($m), 2011-2019
Table 8: Tourette Syndrome Therapeutics Market, France, Revenue ($m), 2006-2011
Table 9: Tourette Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019
Table 10: Tourette Syndrome Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 11: Tourette Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 12: Tourette Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 13: Tourette Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 14: Tourette Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 15: Tourette Syndrome Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 16: Tourette Syndrome Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 17: Tourette Syndrome Therapeutics Market, The UK, Forecast ($m), 2011-2019
Table 18: Tourette Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 19: Tourette Syndrome Therapeutics Market, Japan, Forecast ($m), 2011-2019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 20: Tourette Syndrome Therapeutics - Regulatory and Phase III Pipeline, 2011
Table 21: Tourette Syndrome Therapeutics - Phase II Pipeline, 2011
Table 22: Tourette Syndrome Therapeutics - Phase I Pipeline, 2011
Table 23: Tourette Syndrome Therapeutics - Most Promising Drugs Under Development, 2011
Table 24: Tourette Syndrome Therapeutics Market, Clinical Trials by Region, 2011
Table 25: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Phase of
Development, 2011
Table 26: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011
Table 27: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Prominent
Sponsors, 2011
Table 28: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Top Companies,
2011
Table 29: Otsuka Holdings Co., Ltd- CNS Pipeline Products, 2011
Table 30: Otsuka Holdings Co., Ltd- Tourette Syndrome Pipeline Products, 2011

List Of Figures
Figure 1: Prevalence of Comorbid Conditions Associated with Tourette Syndrome
Figure 2: Treatment and Management of Tourette Syndrome
Figure 3: Referral Pathway
Figure 4: Tourette Syndrome Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 5: Tourette Syndrome Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 6: Tourette Syndrome Therapeutics Market, The US, Revenue ($m), 2006-2011
Figure 7: Tourette Syndrome Therapeutics Market, The US, Forecast ($m), 2011-2019
Figure 8: Tourette Syndrome Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 9: Tourette Syndrome Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 10: Tourette Syndrome Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 11: Tourette Syndrome Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 12: Tourette Syndrome Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 13: Tourette Syndrome Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 14: Tourette Syndrome Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 15: Tourette Syndrome Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 16: Tourette Syndrome Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 17: Tourette Syndrome Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 18: Tourette Syndrome Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 19: Tourette Syndrome Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 20: Strategic Competitor Assessment of the Major Marketed Products in Tourette
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Syndrome, 2011
Figure 21: Tourette Syndrome Therapeutics Pipeline by Phase of Development, 2011
Figure 22: Tourette Syndrome Therapeutic Market - Clinical Pipeline by Mechanism of Action
2011
Figure 23: Technology Trends Analytic Framework for the Tourette Syndrome Therapeutics
Pipeline, 2011
Figure 24: Technology Trends Analytic Framework for the Tourette Syndrome Therapeutics
Pipeline - Description, 2011
Figure 25: Aripiprazole Molecular Structure, 2011
Figure 26: Clinical Trial Details of Aripiprazole
Figure 27: Tourette Syndrome Therapeutics Market, Clinical Trials by Region, 2011
Figure 28: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Phase of
Development, 2011
Figure 29: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011
Figure 30: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Overall Sponsors
(%), 2011
Figure 31: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Prominent
Sponsors, 2011
Figure 32: Tourette Syndrome Therapeutics Market, Global, Clinical Trials by Top Companies,
2011
Figure 33: Tourette Syndrome Therapeutics, Drivers and Barriers, 2011
Figure 34: Implications for Future Market Competition in the Tourette Syndrome Market, 2011
Figure 35: Tourette Syndrome Therapeutics Market - Pipeline by Company, 2011
Figure 36: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Related Reports:
Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Gauchers Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Skin and Skin Structure Infections (SSSI) Therapeutics - Pipeline Assessment and Market Forecasts to
2019
Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Leiomyosarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Waldenstrms Macroglobulinemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Gastrointestinal Stromal Tumors (GIST) Therapeutics - Pipeline Assessment and Market Forecasts to
2019
Retinoblastoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts
to 2019
Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

To know more on Tourette Syndrome Therapeutics - Pipeline Assessment and

Market Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-tourette-syndrometherapeutics-pipeline-assessment-and-market-forecasts-135218

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/